Menu
GeneBe

7-130310917-C-G

Variant summary

Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong

The NM_016352.4(CPA4):ā€‹c.924C>Gā€‹(p.His308Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,614,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.0000066 ( 0 hom., cov: 32)
Exomes š‘“: 6.8e-7 ( 0 hom. )

Consequence

CPA4
NM_016352.4 missense

Scores

4
6
4

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.153
Variant links:
Genes affected
CPA4 (HGNC:15740): (carboxypeptidase A4) This gene is a member of the carboxypeptidase A/B subfamily, and it is located in a cluster with three other family members on chromosome 7. Carboxypeptidases are zinc-containing exopeptidases that catalyze the release of carboxy-terminal amino acids, and are synthesized as zymogens that are activated by proteolytic cleavage. This gene could be involved in the histone hyperacetylation pathway. It is imprinted and may be a strong candidate gene for prostate cancer aggressiveness. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 8 ACMG points.

PM1
In a binding_site (size 0) in uniprot entity CBPA4_HUMAN
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.976

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CPA4NM_016352.4 linkuse as main transcriptc.924C>G p.His308Gln missense_variant 9/11 ENST00000222482.10
CPA4NM_001163446.2 linkuse as main transcriptc.825C>G p.His275Gln missense_variant 8/10
CPA4XM_047420438.1 linkuse as main transcriptc.612C>G p.His204Gln missense_variant 9/11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CPA4ENST00000222482.10 linkuse as main transcriptc.924C>G p.His308Gln missense_variant 9/111 NM_016352.4 P1Q9UI42-1
CPA4ENST00000445470.6 linkuse as main transcriptc.825C>G p.His275Gln missense_variant 8/102 Q9UI42-2
CPA4ENST00000493259.5 linkuse as main transcriptc.612C>G p.His204Gln missense_variant 7/92
CPA4ENST00000488025.1 linkuse as main transcriptn.397C>G non_coding_transcript_exon_variant 2/34

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152182
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461852
Hom.:
0
Cov.:
34
AF XY:
0.00000138
AC XY:
1
AN XY:
727232
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152182
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74332
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 17, 2023The c.924C>G (p.H308Q) alteration is located in exon 9 (coding exon 9) of the CPA4 gene. This alteration results from a C to G substitution at nucleotide position 924, causing the histidine (H) at amino acid position 308 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Pathogenic
0.19
D
BayesDel_noAF
Uncertain
0.040
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.28
T;.;T;T
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Uncertain
0.91
D
M_CAP
Benign
0.059
D
MetaRNN
Pathogenic
0.98
D;D;D;D
MetaSVM
Benign
-1.0
T
MutationAssessor
Pathogenic
3.2
M;.;.;M
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.57
T
Polyphen
1.0
D;.;.;D
Vest4
0.96, 0.98, 0.98
MutPred
0.95
Loss of catalytic residue at S309 (P = 0.2231);.;.;Loss of catalytic residue at S309 (P = 0.2231);
MVP
0.60
MPC
0.56
ClinPred
1.0
D
GERP RS
3.0
Varity_R
0.98
gMVP
0.86

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1765262289; hg19: chr7-129950757; API